Delivery Order SPE2DB22D2007-SPE2DB25FJ0ME
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,590.29, is for the delivery of the prescription medication Qsymia in 3.75 mg-23 mg capsule form. The contract has an ultimate completion date of December 27, 2024 and is a firm fixed-price contract. No set-aside designation was used for this award. AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,463.52 firm-fixed price Delivery Order is for the supply of the prescription medication Qsymia 7.5 mg-46 mg capsules, with a completion date of June 27, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 2025. This single-award IDC...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, provides Qsymia 7.5 mg-46 mg capsules to the Defense Logistics Agency (DLA). The $1,245.70 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and the DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to deliver a range of pharmaceutical products...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,608.40 firm-fixed-price delivery order is for the supply of Qsymia 7.5 mg-46 mg capsules. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA for the delivery of a comprehensive range of medical commodities to support military treatment programs and facilities...
- This federal contract award, with the ID SPE2DB20D3303|SPE2DB24FA0ZE, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp's Corporate Office Division. The $1,419.00 Firm Fixed Price Delivery Order is for the supply of the prescription medication Qsymia 3.75 mg-23 mg capsules in 30-count packages. The contract has a completion date of July 15, 2024 and was awarded on July 12, 2024. This award is not set aside for any specific business type....
- This is a delivery order awarded by the Medical Supply Chain of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Qsymia 3.75mg-23mg capsules. The $1,418.88 firm fixed-price contract has a period of performance through September 11, 2024. It is not a set-aside award. Amerisourcebergen Drug Corp, through its Corporate Office Division, is a key supplier of a wide range of pharmaceutical products and medical supplies to...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,369.40, is for the supply of QSYMIA 15MG-92MG 30S, a prescription medication. The contract has an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $1,646.10 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Qsymia 7.5 mg-46 mg capsules (30-count) under contract 4569035131. The delivery order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-set-aside, competitively awarded procurement. Performance will be executed from the vendor's Conshohocken, Pennsylvania location, which serves as the company's corporate office and...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on December 8, 2025, for supply of Qsymia 3.75 mg-23 mg capsules in a 30-count package. This is a firm fixed-price delivery order with a ceiling value of $1,271.45 and an ultimate completion date of December 9, 2025. The contract was competitively awarded with no set-aside designation. This delivery order is a child contract issued under AmerisourceBergen's...
- This federal contract award is a delivery order valued at $1,630.25, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The contract is for the supply of QSYMIA 3.75 MG-23 MG capsules in 30-count packages. The contract has a firm fixed price and an ultimate completion date of May 29, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier of medical and pharmaceutical products to...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ0MEDelivery Order
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,607.18 firm fixed-price contract is for the delivery of the prescription medication Qsymia 7.5 mg-46 mg capsules. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 4/7/25 |